Minnesota SF 205: Antineoplastic cancer treatment prior authorization prohibition

Status: Comm report: To pass as amended and re-refer to Health and Human Services (as of 2025-03-10)

State: Minnesota · Session: 2025-2026 · Bill: SF 205

Subjects: Commerce and Commerce Department, Hospitals and Health Care Facilities, Insurance-Health

Sponsors: Port, Boldon, Mann, Maye Quade

View Minnesota SF 205 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.